|
24 Sep 2019 |
Anchiano Therapeutics Enters into An Exclusive Option To License Agreement for Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs
|
|
24 Sep 2019 |
Clovis Oncology Acquires Rights to FAP-Targeted Radiopharmaceutical Program from 3B Pharmaceuticals
|
|
20 Sep 2019 |
Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases
|
|
19 Sep 2019 |
Allogene Therapeutics Enters Research Collaboration Directed at Enhancing Future Cancer Immunotherapies
|
|
19 Sep 2019 |
Y-Trap Enters Collaboration with Merck KGaA, Darmstadt, Germany, to Develop Novel Antibody-Ligand Traps for Immuno-Oncology
|
|
17 Sep 2019 |
Oncoheroes Biosciences Inc. and Boehringer Ingelheim International GmbH sign exclusive licensing agreement for volasertib
|
|
16 Sep 2019 |
Lundbeck to acquire Alder BioPharmaceuticals – a company committed to transforming migraine treatment and prevention – in a transaction valued at up to USD 1.95 billion net of cash
|
|
16 Sep 2019 |
Sanofi and Abbott partner to integrate glucose sensing and insulin delivery technologies to help change the way diabetes is managed
|
|
12 Sep 2019 |
Avalon Ventures and COI Pharmaceuticals Announce Acquisition of Sitari Pharmaceuticals by GSK
|
|
12 Sep 2019 |
Tubulis and Glycotope Announce Research and Feasibility Agreement for the Discovery of Antibody Drug Conjugates
|
|
10 Sep 2019 |
Genmab and Tempus Enter into Strategic Collaboration Agreement
|
|
10 Sep 2019 |
Flexion Therapeutics and Xenon Pharmaceuticals Announce Flexion’s Acquisition of an Investigational NaV1.7 Inhibitor for the Treatment of Post-Operative Pain
|
|
10 Sep 2019 |
Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Treatment of Chronic Low Back Pain
|
|
09 Sep 2019 |
Phio Pharmaceuticals Announces Research Collaboration with Carisma Therapeutics to Evaluate its Self-Delivering RNAi Technology to Enhance Macrophage-Based Adoptive Cell Therapy
|
|
09 Sep 2019 |
Alexion and BridgeBio Announce Japanese License Agreement for Eidos’ Transthyretin Amyloidosis (ATTR) Investigational Medicine
|
|
08 Sep 2019 |
RNA-Targeted Small Molecules: new report about hot area of emerging discovery technologies financed by excited investors and pharma partners
|
|
06 Sep 2019 |
IFM Therapeutics Announces Collaboration and Exclusive Option Agreement for cGAS/STING-Focused Subsidiary, IFM Due
|
|
05 Sep 2019 |
Schrödinger Announces Collaboration with AstraZeneca to Deploy Advanced Computing Technology for Drug Discovery
|
|
05 Sep 2019 |
Maruho and X-Chem Announce Drug Discovery Collaboration
|
|
04 Sep 2019 |
BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs
|
|
04 Sep 2019 |
Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound
|
|
03 Sep 2019 |
Vertex to Acquire Semma Therapeutics With a Goal of Developing Curative Cell-Based Treatments for Type 1 Diabetes
|
|
03 Sep 2019 |
Velabs Therapeutics announces strategic partnership with alytas therapeutics to develop a novel immune-based therapy for obesity
|
|
03 Sep 2019 |
Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine
|
|
03 Sep 2019 |
RIKEN and Astellas Enter into Worldwide Exclusive Licensing Agreement for Artificial Adjuvant Vector Cell Technology in Oncology
|
